A submission by FoEA to the European Scientific Committee on Emerging and Newly Identified Health Risks regarding the potential health and environmental risks associated with the increasing use of nano-silver.  In hospitals nano-silver is used extensively for the treatment of wounds, ulcers and skin grafts.  Experts have raised concerns that overuse of this important anti-microbial may result in the development of anti-microbial resistance.

Download Document